Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

A comparison of pharmacoepidemiological study designs in medication use and traffic safety research.

Ravera S, van Rein N, de Gier JJ, de Jong-van den Berg LT.

Eur J Epidemiol. 2012 Jun;27(6):473-81. doi: 10.1007/s10654-012-9689-3. Epub 2012 May 11.

2.

Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.

Dassanayake T, Michie P, Carter G, Jones A.

Drug Saf. 2011 Feb 1;34(2):125-56. doi: 10.2165/11539050-000000000-00000. Review.

PMID:
21247221
3.

Pharmacological interventions for somatoform disorders in adults.

Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ.

Cochrane Database Syst Rev. 2014 Nov 7;(11):CD010628. doi: 10.1002/14651858.CD010628.pub2. Review.

PMID:
25379990
4.

Are selective serotonin reuptake inhibitors safe for drivers? What is the evidence?

Ravera S, Ramaekers JG, de Jong-van den Berg LT, de Gier JJ.

Clin Ther. 2012 May;34(5):1070-83. doi: 10.1016/j.clinthera.2012.04.002. Epub 2012 May 2. Review.

PMID:
22554974
5.

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.

Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L.

Cochrane Database Syst Rev. 2015 May 1;(5):CD011681. doi: 10.1002/14651858.CD011681. Review.

PMID:
25931277
6.

The relationship between benzodiazepine use and traffic accidents: A systematic literature review.

Smink BE, Egberts AC, Lusthof KJ, Uges DR, de Gier JJ.

CNS Drugs. 2010 Aug;24(8):639-53. doi: 10.2165/11533170-000000000-00000. Review.

PMID:
20658797
7.

Atypical antipsychotics for psychosis in adolescents.

Kumar A, Datta SS, Wright SD, Furtado VA, Russell PS.

Cochrane Database Syst Rev. 2013 Oct 15;(10):CD009582. doi: 10.1002/14651858.CD009582.pub2. Review.

PMID:
24129841
8.

Risk of injurious road traffic crash after prescription of antidepressants.

Orriols L, Queinec R, Philip P, Gadegbeku B, Delorme B, Moore N, Suissa S, Lagarde E; CESIR Research Group.

J Clin Psychiatry. 2012 Aug;73(8):1088-94. Review.

9.

Antidepressants for agitation and psychosis in dementia.

Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191. doi: 10.1002/14651858.CD008191.pub2. Review.

PMID:
21328305
10.

Pharmacological interventions for those who have sexually offended or are at risk of offending.

Khan O, Ferriter M, Huband N, Powney MJ, Dennis JA, Duggan C.

Cochrane Database Syst Rev. 2015 Feb 18;(2):CD007989. doi: 10.1002/14651858.CD007989.pub2. Review.

PMID:
25692326
11.

Antidepressants for people with epilepsy and depression.

Maguire MJ, Weston J, Singh J, Marson AG.

Cochrane Database Syst Rev. 2014 Dec 3;(12):CD010682. doi: 10.1002/14651858.CD010682.pub2. Review.

PMID:
25464360
12.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Eke AC, Saccone G, Berghella V.

BJOG. 2016 Nov;123(12):1900-1907. doi: 10.1111/1471-0528.14144. Epub 2016 May 30. Review.

13.

Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.

Petersen I, McCrea RL, Sammon CJ, Osborn DP, Evans SJ, Cowen PJ, Freemantle N, Nazareth I.

Health Technol Assess. 2016 Mar;20(23):1-176. doi: 10.3310/hta20230. Review.

14.

The epidemiologic principles underlying traffic safety study designs.

Kim JH, Mooney SJ.

Int J Epidemiol. 2016 Oct;45(5):1668-1675. Epub 2016 Aug 14. Review.

15.
16.

[Hepatic tolerance of atypical antipsychotic drugs].

Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora JF, Aubriot-Delmas B, Glikman J, Januel D.

Encephale. 2002 Nov-Dec;28(6 Pt 1):542-51. Review. French.

PMID:
12506267
17.

The more you drink, the harder you fall: a systematic review and meta-analysis of how acute alcohol consumption and injury or collision risk increase together.

Taylor B, Irving HM, Kanteres F, Room R, Borges G, Cherpitel C, Greenfield T, Rehm J.

Drug Alcohol Depend. 2010 Jul 1;110(1-2):108-16. doi: 10.1016/j.drugalcdep.2010.02.011. Epub 2010 Mar 16. Review.

18.

The use of psychotropic medication during pregnancy: how about the newborn?

Kieviet N, Dolman KM, Honig A.

Neuropsychiatr Dis Treat. 2013;9:1257-66. doi: 10.2147/NDT.S36394. Epub 2013 Aug 28. Review.

19.

Drug exposure and the risk of multiple sclerosis: A systematic review.

Yong HY, McKay KA, Daley CGJ, Tremlett H.

Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):133-139. doi: 10.1002/pds.4357. Epub 2017 Dec 6. Review.

PMID:
29210147
20.

[Case-crossover studies. Research into risk factors with the patient as his or her own control].

Roach RE, Siegerink B, Lijfering WM.

Ned Tijdschr Geneeskd. 2013;157(28):A5896. Review. Dutch.

PMID:
23841926

Supplemental Content

Support Center